LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

RNA Binding Protein Required for Successful Infection by HCMV

By LabMedica International staff writers
Posted on 03 Nov 2016
Image: Human CPEB1 protein is shown here in green, while cytomegalovirus (HCMV) is orange (Photo courtesy of the University of California, San Diego).
Image: Human CPEB1 protein is shown here in green, while cytomegalovirus (HCMV) is orange (Photo courtesy of the University of California, San Diego).
A team of molecular virologists has catalogued the interactions that occur at the genetic level when cytomegalovirus (HCMV) infects human cells.

Investigators at the University of California, San Diego (USA) performed comprehensive transcriptome-wide analyses to better understand interactions occurring at the post-transcriptional level between the human host and HCMV.

They reported in the October 24, 2016, online edition of the journal Nature Structural and Molecular Biology that the host RNA-binding protein CPEB1 (Cytoplasmic polyadenylation element-binding protein 1) was highly induced after infection. Introduction of CPEB1 into uninfected cells recapitulated the infection-related post-transcriptional changes seen in host cells that had been invaded by HCMV.

CPEB1 was also required for poly(A)-tail lengthening of viral RNAs important for productive infection. Furthermore, depletion of CPEB1 reversed infection-related cytopathology and post-transcriptional changes, and decreased productive HCMV titers.

“We found that CPEB1, one of a family of hundreds of RNA-binding proteins in the human genome, is important for establishing productive cytomegalovirus infections,” said senior author Dr. Gene Yeo, professor of cellular and molecular medicine at the University of California, San Diego. “The next steps are to determine the therapeutic value of inhibiting CPEB1 in HCMV infections and identify other RNA-binding proteins that may be important in other viral infections.”

Related Links:
University of California, San Diego

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more